Option chain shows key data for Chimeric Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Chimeric Therapeutics.

Chimeric Therapeutics (OTC:CHMMF) Stock, Option Chain

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.

CHIMERIC THERAPEAUTCS LTD by CHIMERIC THERAPEAUTICS LTD.

Comments

Chimeric Therapeutics

Chimeric Therapeutics (CHMMF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell